Taiwan FDA registration c795fcb14706a78710ea1e2f62a0e317
Revel Heme Test System
TW: 露華血紅素測試系統
Taiwan·Risk Class 2·NOVA BIOMEDICAL TAIWAN CORP.·Registered Dec 04, 2019 – Dec 04, 2024ExpiredRegistration details
- Analysis ID
- c795fcb14706a78710ea1e2f62a0e317
Company information
- Manufacturer
- NOVA BIOMEDICAL TAIWAN CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- NOVA BIOMEDICAL TAIWAN CORP.
Product details
- Intended Use
- This product can be used to self-measure the heme content of fingertip microvascular whole blood, but is not suitable for neonatal testing.
- Product Type (Level 1)
- B Hematology, Pathology and Genetics;; I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.4800 Surgical Hand Instruments for General Surgery;; B.7500 Whole blood hemoglobin analysis
- Import Information
- Domestic
Dates and status
- Registration Date
- Dec 04, 2019
- Expiry Date
- Dec 04, 2024
About this record
Access comprehensive regulatory information for Revel Heme Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c795fcb14706a78710ea1e2f62a0e317 and manufactured by NOVA BIOMEDICAL TAIWAN CORP.. The authorized representative in Taiwan is NOVA BIOMEDICAL TAIWAN CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices